VIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 16.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $19,497,498.05

Vir Biotechnology Insider Trading History Chart

Vir Biotechnology Share Price & Price History

^$6.78

▲ +0.51 (8.13%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Vir Biotechnology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	191,854	$5.98	$1,147,286.92	13,728,924
12/1/2025	Vicki L. Sato	Director	Sell	22,000	$6.00	$132,000.00	1,188,391
11/28/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	61,493	$6.44	$396,014.92	13,920,778
11/26/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	127,938	$6.39	$817,523.82	13,982,271
11/25/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	235,971	$6.38	$1,505,494.98	14,110,209
11/24/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	227,803	$6.15	$1,400,988.45	14,346,180
11/17/2025	Jason O'byrne	CFO	Sell	6,799	$5.56	$37,802.44	110,701
11/5/2025	Vanina de Verneuil	EVP	Sell	2,385	$5.16	$12,306.60	78,210
11/3/2025	Vanina de Verneuil	EVP	Sell	1,365	$5.86	$7,998.90	80,595
11/3/2025	Vicki L. Sato	Director	Sell	22,000	$5.64	$124,080.00	1,210,391
10/29/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	100	$6.49	$649.00	14,573,983
10/28/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	24,453	$6.50	$158,944.50	14,574,083
10/27/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	66,403	$6.05	$401,738.15	14,598,536
10/24/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	46,696	$5.96	$278,308.16	14,664,939
10/23/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	154,383	$5.99	$924,754.17	14,711,635
10/22/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	144,266	$6.15	$887,235.90	14,866,018
10/21/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	109,675	$6.30	$690,952.50	15,010,284
10/20/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	220,535	$6.20	$1,367,317.00	15,119,959
10/16/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	12,844	$6.10	$78,348.40	15,340,494
10/15/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	16,671	$6.07	$101,192.97	15,353,338
10/10/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	2,300	$6.08	$13,984.00	15,370,009
10/9/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	249,060	$6.14	$1,529,228.40	15,372,309
10/8/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	466,242	$6.05	$2,820,764.10	15,621,369
10/7/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	72,133	$5.60	$403,944.80	16,087,611
10/6/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	73,955	$5.69	$420,803.95	16,159,744
10/3/2025	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	450,342	$5.56	$2,503,901.52	16,233,699
10/1/2025	Vicki L. Sato	Director	Sell	22,000	$5.84	$128,480.00	1,232,391
9/2/2025	Vicki L. Sato	Director	Sell	22,000	$4.99	$109,780.00	1,254,391
8/1/2025	Vicki L. Sato	Director	Sell	22,000	$4.99	$109,780.00	1,276,391
7/17/2025	Mark Eisner	EVP	Sell	3,586	$5.47	$19,615.42	104,618
7/15/2025	Mark Eisner	EVP	Sell	6,796	$5.47	$37,174.12	108,204
7/1/2025	Vicki L. Sato	Director	Sell	22,000	$5.10	$112,200.00	1,298,391
6/2/2025	Janet Napolitano	Director	Sell	3,200	$5.05	$16,160.00	16,416
4/3/2025	Marianne De Backer	CEO	Sell	79,712	$5.95	$474,286.40	769,505
2/26/2025	Vanina de Verneuil	EVP	Sell	7,373	$9.14	$67,389.22	79,460
2/18/2025	George A. Scangos	Director	Sell	10,964	$9.81	$107,556.84	708,295
2/13/2025	Brent Sabatini	CAO	Sell	1,562	$9.15	$14,292.30	28,189
1/8/2025	Vicki L. Sato	Director	Sell	10,960	$12.52	$137,219.20	1,312,391
12/2/2024	Vanina de Verneuil	EVP	Sell	76	$8.22	$624.72	56,973
11/5/2024	Vanina de Verneuil	EVP	Sell	2,347	$9.47	$22,226.09	61,370
11/1/2024	Vanina de Verneuil	EVP	Sell	1,403	$7.20	$10,101.60	63,717
9/9/2024	Janet Napolitano	Director	Sell	12,190	$7.80	$95,082.00	11,616
6/11/2024	Saira Ramasastry	Director	Sell	4,000	$10.95	$43,800.00	14,619
4/3/2024	Marianne De Backer	CEO	Sell	72,995	$9.46	$690,532.70	678,457
4/1/2024	Ann M. Hanly	EVP	Sell	2,711	$10.05	$27,245.55	132,069
3/27/2024	Sung Lee	CFO	Sell	6,008	$9.89	$59,419.12	100,492
2/26/2024	George A. Scangos	Director	Sell	17,722	$11.65	$206,461.30	112,989
2/22/2024	Ann M. Hanly	EVP	Sell	12,296	$10.05	$123,574.80	134,780
2/22/2024	George A. Scangos	Director	Sell	10,028	$10.05	$100,781.40	130,711
2/20/2024	George A. Scangos	Director	Sell	16,872	$10.22	$172,431.84	140,739
2/16/2024	George A. Scangos	Director	Sell	10,878	$10.24	$111,390.72	157,611
2/16/2024	Phillip Pang	EVP	Sell	3,321	$10.24	$34,007.04	264,679
6/30/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	700	$25.11	$17,577.00	16,684,041
6/30/2023	Vicki L. Sato	Director	Sell	18,000	$24.66	$443,880.00	1,315,351
6/28/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	7,010	$25.10	$175,951.00	16,774,683
6/20/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	9,902	$25.18	$249,332.36	16,781,693
6/15/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	55,182	$25.85	$1,426,454.70	16,919,739
6/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	106,854	$27.09	$2,894,674.86	17,032,169
6/7/2023	Phillip Pang	Insider	Sell	5,000	$25.95	$129,750.00	188,000
6/5/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	5,197	$27.32	$141,982.04	17,139,023
6/2/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	34,365	$27.32	$938,851.80	17,144,220
6/1/2023	Saira Ramasastry	Director	Sell	3,500	$25.67	$89,845.00	10,619
6/1/2023	Steven J. Rice	Insider	Sell	2,500	$25.67	$64,175.00	106,840
5/24/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	104,384	$26.15	$2,729,641.60	17,178,585
5/22/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	91,896	$25.72	$2,363,565.12	17,453,036
5/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	91,651	$25.38	$2,326,102.38	17,544,932
5/5/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	136	$25.10	$3,413.60	17,636,583
5/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	83,674	$25.51	$2,134,523.74	17,751,051
5/1/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	3,075	$25.30	$77,797.50	17,834,725
4/24/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	66,038	$25.42	$1,678,685.96	17,838,761
4/21/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	305,393	$25.78	$7,873,031.54	17,904,799
4/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	76,114	$25.12	$1,911,983.68	18,216,782
4/17/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	10,524	$25.06	$263,731.44	18,299,849
4/14/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	9,565	$25.11	$240,177.15	18,310,373
3/30/2023	Ann M. Hanly	CTO	Sell	2,627	$22.77	$59,816.79	114,576
3/8/2023	Vicki L. Sato	Director	Sell	17,935	$22.59	$405,151.65	1,327,324
3/3/2023	Johanna Friedl-Naderer	COO	Sell	1,482	$22.82	$33,819.24	148,518
2/23/2023	Ann M. Hanly	CTO	Sell	2,302	$25.97	$59,782.94	117,203
2/23/2023	George A. Scangos	CEO	Sell	12,631	$25.97	$328,027.07	183,608
2/23/2023	Howard Horn	CFO	Sell	2,248	$25.97	$58,380.56	230,712
2/23/2023	Phillip Pang	Insider	Sell	2,878	$25.97	$74,741.66	198,320
2/21/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	74,477	$28.43	$2,117,381.11	18,319,938
2/21/2023	George A. Scangos	CEO	Sell	17,856	$28.30	$505,324.80	196,239
2/17/2023	George A. Scangos	CEO	Sell	9,894	$25.29	$250,219.26	214,095
2/17/2023	Howard Horn	CFO	Sell	2,424	$25.29	$61,302.96	232,960
2/17/2023	Steven J. Rice	Insider	Sell	1,981	$25.29	$50,099.49	37,209
2/15/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	38,964	$26.75	$1,042,287.00	18,394,415
2/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	79,050	$26.02	$2,056,881.00	18,472,286
2/10/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	97,221	$26.13	$2,540,384.73	18,551,336
2/8/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	81,914	$27.88	$2,283,762.32	18,785,607
2/8/2023	Vicki L. Sato	Director	Sell	17,915	$28.38	$508,427.70	1,345,259
2/6/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	45,249	$29.92	$1,353,850.08	18,931,029
2/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	68,786	$30.40	$2,091,094.40	18,976,278
2/1/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	61,834	$29.02	$1,794,422.68	19,131,865
1/30/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	78,930	$29.46	$2,325,277.80	19,267,582
1/24/2023	Phillip Pang	Insider	Sell	30,000	$30.00	$900,000.00	144,000
1/23/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	36,512	$28.34	$1,034,750.08	19,346,512
1/19/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	69,839	$26.56	$1,854,923.84	19,527,382
1/17/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	88,372	$26.24	$2,318,881.28	19,699,688
1/13/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	94,199	$26.54	$2,500,041.46	19,788,060
1/11/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	79,065	$26.24	$2,074,665.60	19,999,738
1/9/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	34,801	$25.85	$899,605.85	20,149,378
1/9/2023	Vicki L. Sato	Director	Sell	17,915	$25.83	$462,744.45	1,363,174
1/6/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	66,179	$26.13	$1,729,257.27	20,184,179
1/5/2023	Charles Elliott Sigal	Director	Buy	2,500	$24.96	$62,400.00	7,500
1/3/2023	Charles Elliott Sigal	Director	Buy	2,500	$25.60	$64,000.00	2,500
1/3/2023	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	8,177	$25.58	$209,167.66	20,251,358
12/27/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	6,850	$25.59	$175,291.50	20,303,704
12/22/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	95,144	$26.07	$2,480,404.08	20,390,635
12/20/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	104,026	$25.53	$2,655,783.78	20,597,509
12/5/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	8,831	$27.25	$240,644.75	20,701,535
12/2/2022	Endurance (Cayman) Ltd Svf	Major Shareholder	Sell	88,462	$27.47	$2,430,051.14	20,710,366

SEC Filings (Institutional Ownership Changes) for Vir Biotechnology (NASDAQ:VIR)

65.32% of Vir Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vir Biotechnology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Jacobs Levy Equity Management Inc.	96,717	$0.55M	0.0%	-33.4%	0.070%
11/17/2025	Connective Capital Management LLC	75,470	$0.43M	0.4%	N/A	0.054%
11/17/2025	Sender Co & Partners Inc.	43,175	$0.25M	0.0%	N/A	0.031%
11/17/2025	Dark Forest Capital Management LP	143,068	$0.82M	0.0%	N/A	0.103%
11/17/2025	XTX Topco Ltd	139,896	$0.80M	0.0%	N/A	0.101%
11/17/2025	Susquehanna Fundamental Investments LLC	263,897	$1.51M	0.1%	-12.1%	0.190%
11/17/2025	Qube Research & Technologies Ltd	272,170	$1.55M	0.0%	-38.1%	0.196%
11/17/2025	Prelude Capital Management LLC	19,000	$0.11M	0.0%	N/A	0.014%
11/17/2025	Millennium Management LLC	1,396,504	$7.97M	0.0%	+129.2%	1.004%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	105,965	$0.61M	0.0%	N/A	0.076%
11/17/2025	Jain Global LLC	18,376	$0.11M	0.0%	N/A	0.013%
11/17/2025	Cinctive Capital Management LP	24,183	$0.14M	0.0%	-72.6%	0.017%
11/17/2025	Bank of America Corp DE	400,983	$2.29M	0.0%	-5.8%	0.288%
11/17/2025	Boothbay Fund Management LLC	158,123	$0.90M	0.0%	-48.4%	0.114%
11/17/2025	Ameriprise Financial Inc.	194,269	$1.11M	0.0%	-8.1%	0.140%
11/14/2025	Creative Planning	52,676	$0.30M	0.0%	+39.5%	0.038%
11/14/2025	Man Group plc	70,477	$0.40M	0.0%	-72.6%	0.051%
11/14/2025	California State Teachers Retirement System	108,315	$0.62M	0.0%	+30.2%	0.078%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	143,938	$0.82M	0.0%	-51.1%	0.103%
11/14/2025	Two Sigma Investments LP	649,300	$3.71M	0.0%	+75.7%	0.467%
11/14/2025	Squarepoint Ops LLC	277,315	$1.58M	0.0%	+158.3%	0.199%
11/14/2025	iSAM Funds UK Ltd	17,086	$98K	0.0%	N/A	0.012%
11/14/2025	Comerica Bank	23,073	$0.13M	0.0%	-13.8%	0.017%
11/13/2025	Sei Investments Co.	25,052	$0.14M	0.0%	-35.5%	0.018%
11/13/2025	UBS Group AG	214,762	$1.23M	0.0%	-31.9%	0.154%
11/13/2025	BNP Paribas Financial Markets	19,146	$0.11M	0.0%	+87.0%	0.014%
11/13/2025	Franklin Resources Inc.	205,994	$1.18M	0.0%	-18.5%	0.148%
11/13/2025	Legal & General Group Plc	244,971	$1.40M	0.0%	-1.5%	0.176%
11/13/2025	WINTON GROUP Ltd	57,751	$0.33M	0.0%	N/A	0.042%
11/13/2025	Russell Investments Group Ltd.	29,627	$0.17M	0.0%	-58.8%	0.021%
11/13/2025	Schroder Investment Management Group	456,292	$2.57M	0.0%	-45.7%	0.328%
11/12/2025	Barclays PLC	410,406	$2.34M	0.0%	-13.4%	0.295%
11/12/2025	Dimensional Fund Advisors LP	2,978,871	$17.01M	0.0%	-1.0%	2.141%
11/12/2025	Victory Capital Management Inc.	14,771	$84K	0.0%	-13.9%	0.011%
11/12/2025	Rafferty Asset Management LLC	114,785	$0.66M	0.0%	-13.1%	0.083%
11/12/2025	Intech Investment Management LLC	40,726	$0.23M	0.0%	-16.9%	0.029%
11/10/2025	Citigroup Inc.	323,525	$1.85M	0.0%	-22.2%	0.233%
11/10/2025	China Universal Asset Management Co. Ltd.	24,350	$0.14M	0.0%	-12.3%	0.018%
11/7/2025	GSA Capital Partners LLP	14,746	$84K	0.0%	-78.3%	0.011%
11/7/2025	Vanguard Group Inc.	12,799,381	$73.08M	0.0%	-3.2%	9.214%
11/7/2025	JPMorgan Chase & Co.	449,518	$2.57M	0.0%	+1.4%	0.324%
11/7/2025	Aberdeen Group plc	1,526,265	$8.72M	0.0%	+51.6%	1.099%
11/6/2025	Public Sector Pension Investment Board	367,264	$2.10M	0.0%	+16.9%	0.264%
11/6/2025	Rhumbline Advisers	226,799	$1.30M	0.0%	-0.9%	0.163%
11/6/2025	Profund Advisors LLC	27,660	$0.16M	0.0%	-8.3%	0.020%
11/6/2025	ProShare Advisors LLC	21,820	$0.13M	0.0%	-13.1%	0.016%
11/5/2025	Alps Advisors Inc.	66,109	$0.38M	0.0%	-11.3%	0.048%
11/4/2025	Allianz Asset Management GmbH	284,227	$1.62M	0.0%	-13.3%	0.205%
11/4/2025	Jones Financial Companies Lllp	18,234	$100K	0.0%	+53,529.4%	0.013%
11/4/2025	Principal Financial Group Inc.	455,700	$2.60M	0.0%	-0.7%	0.328%
11/3/2025	New York State Common Retirement Fund	24,606	$0.14M	0.0%	-62.1%	0.018%
11/3/2025	Federated Hermes Inc.	8,085	$46K	0.0%	+153.8%	0.006%
11/3/2025	Truist Financial Corp	11,115	$63K	0.0%	N/A	0.008%
10/29/2025	Wealth Enhancement Advisory Services LLC	11,065	$63K	0.0%	-30.8%	0.008%
10/29/2025	Maryland State Retirement & Pension System	13,495	$77K	0.0%	-51.3%	0.010%
10/27/2025	Nordea Investment Management AB	714,561	$3.93M	0.0%	+1.4%	0.514%
10/24/2025	State of Alaska Department of Revenue	47,531	$0.27M	0.0%	-13.7%	0.034%
10/23/2025	SG Americas Securities LLC	69,028	$0.39M	0.0%	+84.2%	0.050%
10/17/2025	Apollon Wealth Management LLC	20,000	$0.11M	0.0%	+100.0%	0.014%
10/15/2025	CWM LLC	7,158	$41K	0.0%	-55.1%	0.005%
10/14/2025	Yousif Capital Management LLC	23,843	$0.14M	0.0%	-13.5%	0.017%
10/14/2025	Clarius Group LLC	619,312	$3.54M	0.2%	+0.3%	0.446%
10/9/2025	Voya Investment Management LLC	16,795	$96K	0.0%	-32.3%	0.012%
8/27/2025	Squarepoint Ops LLC	107,360	$0.54M	0.0%	+99.9%	0.077%
8/18/2025	Hudson Bay Capital Management LP	696,000	$3.51M	0.0%	+17.7%	0.501%
8/16/2025	Public Sector Pension Investment Board	314,176	$1.58M	0.0%	+7.4%	0.226%
8/15/2025	Corient Private Wealth LLC	518,684	$2.61M	0.0%	+100.7%	0.373%
8/15/2025	Captrust Financial Advisors	30,739	$0.16M	0.0%	+39.7%	0.022%
8/15/2025	Rafferty Asset Management LLC	132,021	$0.67M	0.0%	-22.9%	0.095%
8/15/2025	Man Group plc	256,918	$1.30M	0.0%	+178.7%	0.185%
8/15/2025	LMR Partners LLP	167,800	$0.85M	0.0%	+13.5%	0.121%
8/15/2025	Hudson Bay Capital Management LP	696,000	$3.51M	0.0%	+17.7%	0.501%
8/15/2025	Engineers Gate Manager LP	56,730	$0.29M	0.0%	-57.5%	0.041%
8/15/2025	BNP Paribas Financial Markets	10,240	$52K	0.0%	-74.9%	0.007%
8/15/2025	Brevan Howard Capital Management LP	34,743	$0.18M	0.0%	-66.7%	0.025%
8/15/2025	Bank of America Corp DE	425,701	$2.15M	0.0%	-9.6%	0.306%
8/15/2025	Ameriprise Financial Inc.	211,388	$1.07M	0.0%	-1.1%	0.152%
8/15/2025	ARCH Venture Management LLC	12,916,663	$65.10M	21.8%	N/A	9.298%
8/14/2025	Orbimed Advisors LLC	2,380,715	$12M	0.3%	+5.9%	1.714%
8/14/2025	Raymond James Financial Inc.	7,018	$35K	0.0%	N/A	0.005%
8/14/2025	The Manufacturers Life Insurance Company	45,144	$0.23M	0.0%	-6.3%	0.032%
8/14/2025	Sei Investments Co.	38,820	$0.20M	0.0%	+125.2%	0.028%
8/14/2025	Qube Research & Technologies Ltd	440,005	$2.22M	0.0%	+51.4%	0.317%
8/14/2025	Daiwa Securities Group Inc.	12,308	$62K	0.0%	+2,200.6%	0.009%
8/14/2025	Cerity Partners LLC	33,903	$0.17M	0.0%	+125.7%	0.024%
8/13/2025	Cresset Asset Management LLC	14,244	$72K	0.0%	-17.9%	0.010%
8/13/2025	Amundi	14,580	$79K	0.0%	-60.2%	0.010%
8/13/2025	Stonepine Capital Management LLC	130,000	$0.66M	0.6%	-10.1%	0.094%
8/13/2025	Sio Capital Management LLC	478,343	$2.41M	0.9%	+1.0%	0.344%
8/13/2025	Panagora Asset Management Inc.	97,327	$0.49M	0.0%	N/A	0.070%
8/13/2025	Virtus Investment Advisers LLC	18,014	$91K	0.0%	-18.5%	0.013%
8/13/2025	Tejara Capital Ltd	258,600	$1.30M	0.6%	+12.6%	0.186%
8/13/2025	Russell Investments Group Ltd.	71,881	$0.36M	0.0%	+10.9%	0.052%
8/12/2025	Prudential Financial Inc.	610,452	$3.08M	0.0%	-8.7%	0.439%
8/12/2025	American Century Companies Inc.	273,708	$1.38M	0.0%	+6.2%	0.197%
8/12/2025	Rhumbline Advisers	228,949	$1.15M	0.0%	+1.0%	0.165%
8/12/2025	Franklin Resources Inc.	252,714	$1.27M	0.0%	+21.1%	0.182%
8/12/2025	Legal & General Group Plc	248,726	$1.25M	0.0%	+5.9%	0.179%
8/12/2025	JPMorgan Chase & Co.	443,375	$2.24M	0.0%	+0.9%	0.319%
8/12/2025	Swiss National Bank	170,200	$0.86M	0.0%	-2.6%	0.123%

Data available starting January 2016

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Today's Range

Now: $6.78

$6.11

$6.93

50 Day Range

MA: $5.83

$5.12

$6.78

52 Week Range

Now: $6.78

$4.16

$14.45

Volume

3,524,154 shs

Average Volume

1,586,429 shs

Market Capitalization

$943.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Vir Biotechnology?: Vir Biotechnology's top insider investors include:
Endurance (Cayman) Ltd Svf (Major Shareholder)
Vicki L Sato (Director)
Backer Marianne De (CEO)
George A Scangos (Director)
Phillip Pang (EVP)
Ann M Hanly (EVP)
Jason O'byrne (CFO)
Mark Eisner (EVP)
Sung Lee (CFO)
Verneuil Vanina De (EVP)
Brent Sabatini (CAO)
Janet Napolitano (Director)
Saira Ramasastry (Director)
Learn More about top insider investors at Vir Biotechnology.
Who are the major institutional investors of Vir Biotechnology?: Vir Biotechnology's top institutional investors include:
Vanguard Group Inc. — 9.21%
Dimensional Fund Advisors LP — 2.14%
Aberdeen Group plc — 1.10%
Millennium Management LLC — 1.00%
Nordea Investment Management AB — 0.51%
Two Sigma Investments LP — 0.47%
Learn More about top institutional investors of Vir Biotechnology stock.
Which institutional investors are selling Vir Biotechnology stock?: In the previous quarter, VIR stock was sold by these institutional investors:
Vanguard Group Inc.
Schroder Investment Management Group
Man Group plc
Qube Research & Technologies Ltd
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC
Boothbay Fund Management LLC
UBS Group AG
Citigroup Inc.
In the last year, company insiders that have sold Vir Biotechnology company stock include:
Endurance (Cayman) Ltd Svf (Major Shareholder)
Vicki L Sato (Director)
Backer Marianne De (CEO)
George A Scangos (Director)
Phillip Pang (EVP)
Ann M Hanly (EVP)
Jason O'byrne (CFO)
Mark Eisner (EVP)
Sung Lee (CFO)
Learn More investors selling Vir Biotechnology stock.
Which institutional investors are buying Vir Biotechnology stock?: During the previous quarter, VIR stock was bought by institutional investors including:
Millennium Management LLC
Aberdeen Group plc
Two Sigma Investments LP
Squarepoint Ops LLC
Dark Forest Capital Management LP
XTX Topco Ltd
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Connective Capital Management LLC